GLPBio

Salidroside

Catalog No.: GN10127Purity:>98.50%Synonyms: Rhodioloside
Salidroside is a tyrosol glycoside primarily found in the roots of Rhodiola species, exhibiting a wide range of biological and pharmacological properties, including anti-cancer, antioxidant, anti-aging, anti-diabetic, anti-hypertensive, anti-inflammatory, and immunomodulatory effects.

Products are for research use only. Not for human use. We do not sell to patients.


Salidroside
Cas No.: 10338-51-9
10mM (in 1mL Water)In Stock
$42.00
1
5mgIn Stock
$39.00
1
10mgIn Stock
$62.00
1

Citations

1 publicationsPublications from researchers using this product

Description

Salidroside is a tyrosol glycoside primarily found in the roots of Rhodiola species, exhibiting a wide range of biological and pharmacological properties, including anti-cancer, antioxidant, anti-aging, anti-diabetic, anti-hypertensive, anti-inflammatory, and immunomodulatory effects. Salidroside can improve muscle nutrition by increasing the expression of mTOR, p-mTOR, and MyHC[1]. It alleviates cachexia symptoms in a mouse model of cancer cachexia by activating the mTOR signaling pathway[1]. Furthermore, salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy[2]. Its anti-cancer activity is primarily due to the inhibition of the PI3K/AKT, JAK/STAT, and MEK/ERK pathways, as well as the activation of cell apoptosis and autophagy[3].

In vitro, salidroside significantly increases the expression of mTOR, p-mTOR, and MyHC in C2C12 myotubes and can effectively rescue the downregulation of mTOR, p-mTOR, and MyHC expression induced by tumor necrosis factor-alpha[1]. Salidroside (10, 25, and 50µM) significantly prevents MPP+-induced cytotoxicity and reverses the reduction in dopamine, HVA, and DOPAC levels induced by MPTP in the striatum[2]. Additionally, salidroside (100µM) inhibits the activity of prolyl endopeptidase (PEP), an enzyme associated with learning and memory, by 10.6±1.9%[4].

In vivo, salidroside (120 mg/kg/day; i.p.) significantly maintains fat mass and increases lean body mass, especially the mass of the gastrocnemius muscle, indicating a notable improvement in the main features of cancer-associated cachexia in mice[1]. Salidroside (10/20/40 mg/kg/day) also induces a mouse model of testicular damage[5].

References:
[1] Chen X, et al. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activatingmTOR signalling. J Cachexia Sarcopenia Muscle. 2016 May;7(2):225-32.
[2]Li R, et al. Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. Oxid Med Cell Longev. 2019 Sep 10; 2019: 9341018.
[3] Zhifeng Z , Jing H , Jizhou Z ,et al.Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system[J].Drug Design Development & Therapy, 2018, 12:1479-1489.
[4] Fan W, et al. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sachalinensis. Chem Pharm Bull (Tokyo). 2001 Apr;49(4):396-401.
[5] Wang Z, et al. Salidroside Ameliorates Furan-Induced Testicular Inflammation in Relation to the Gut-Testis Axis and Intestinal Apoptosis. J Agric Food Chem. 2023 Nov 9.

Protocol

Cell experiment [1]:

Cell lines

MN9D cells

Preparation Method

MN9D cells were cultured in RPMI medium with 10% FBS in a humidified atmosphere incubator of 5% CO2 at 37°C. The cells were pretreated with Salidroside(10, 25, and 50 µM) for 24 h and incubated with 200 µM of MPP+ for an additional 24 h based on a previous dose-effect study

Reaction Conditions

0, 25, 50 µM; 24 h

Applications

200 µM of MPP+ remarkably reduced the cell viability, and Salidroside (10, 25, and 50 µM) markedly prevented the cell toxicity induced by MPP+.

Animal experiment [2]:

Animal models

BABL/c and C57BL/6 mice

Preparation Method

BABL/c mice were inoculated with CT-26 cells (1.0×106/100 µL), while C57BL/6 mice with LLC cells (7×105/100 µL), both of them were injected s.c. into the right flank. Nine days after inoculation, tumours were palpable (about 5 mm in diameter) in BABL/c and C57BL/6 mice, respectively. Treatments were given i.p. with the control group, salidroside (60 mg/kg/day), and salidroside (120 mg/kg/day) for 25 days in BABL/c tumour model, while for 20 days in C57BL/6 model.

Dosage form

60 mg/kg/day、120 mg/kg/day; i.p.

Applications

salidroside had an effective anti-cachexia activity in CAC models in vivo, including increasing quality of life and prolonging survival time.

References:

[1]Li R, et al. Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. Oxid Med Cell Longev. 2019 Sep 10; 2019: 9341018.
[2] Chen X, et al. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activatingmTOR signalling. J Cachexia Sarcopenia Muscle. 2016 May;7(2):225-32.

Product Documents

Purity:>98.50%Appearance:A solid

Chemical Properties

CAS No.
10338-51-9
Synonyms
Rhodioloside
Chemical Name
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol
SMILES
C1=CC(=CC=C1CCOC2C(C(C(C(O2)CO)O)O)O)O
Molecular Formula
C14H20O7
Molecular Weight
300.3
Solubility
≥ 30mg/mL in DMSO,≥100 mg/mL in Water.Measured
Storage
4°C, protect from light
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Salidroside

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%